Douglas Cartwright
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
- Oncology 6
- PARP inhibition in cancer therapy 3
-
- Breast Cancer Treatment Studies 2
- Cancer Genomics and Diagnostics 1
- Co-authors
- Matthew Evison (1 shared paper)Christopher John Fong (1 shared paper)Selina Tsim (1 shared paper)Laura E. Crotty Alexander (1 shared paper)Kevin G. Blyth (1 shared paper)Caroline Kelly (1 shared paper)Jayne Holme (1 shared paper)Alistair S. McLaren (5 shared papers)
- Journals
- The Lancet (6 papers)Annals of Oncology (2 papers)Lung Cancer (1 paper)Clinical Oncology (1 paper)Current Issues in Criminal Justice (1 paper)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Douglas Cartwright
22 papers receiving 1.6k citations
Douglas Cartwright's Hit Papers
Peers
Comparison fields: 5 of 104
- Infectious Diseases 963
- Applied Microbiology and Biotechnology 50
- Neurology 345
- Internal Medicine 56
- Critical Care and Intensive Care Medicine 59
Countries citing papers authored by Douglas Cartwright
This map shows the geographic impact of Douglas Cartwright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Cartwright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Cartwright more than expected).
Fields of papers citing papers by Douglas Cartwright
This network shows the impact of papers produced by Douglas Cartwright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Cartwright. The network helps show where Douglas Cartwright may publish in the future.
Co-authors
The 25 scholars most cited alongside Douglas Cartwright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 5 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 6 | 2023 | 83 | |
| 7 | 2019 | 24 | |
| 8 | 2023 | 24 | |
| 9 | 2024 | 23 | |
| 10 | 2023 | 5 | |
| 11 | 2025 | 5 | |
| 12 | 2021 | 4 | |
| 13 | 2023 | 4 | |
| 14 | Intraoperative cytology as an elective surgical procedure. Analysis of 57 cases. | 1993 | 2 |
| 15 | 2025 | 2 | |
| 16 | 2025 | 2 | |
| 17 | 2002 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2024 | 1 |
About Douglas Cartwright
Douglas Cartwright is a scholar working on Oncology, Cancer Research, Reproductive Medicine, Infectious Diseases and Surgery, having authored 25 papers that have together received 1.7k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), PARP inhibition in cancer therapy (3 papers), Ovarian cancer diagnosis and treatment (2 papers), Breast Cancer Treatment Studies (2 papers), Art History and Market Analysis (1 paper), Cancer Genomics and Diagnostics (1 paper), Diabetes and associated disorders (1 paper) and Chemotherapy-induced cardiotoxicity and mitigation (1 paper). The work is most often cited by research in Infectious Diseases (963 citations), Applied Microbiology and Biotechnology (50 citations), Neurology (345 citations), Internal Medicine (56 citations) and Critical Care and Intensive Care Medicine (59 citations). Douglas Cartwright has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Matthew Evison, Christopher John Fong, Selina Tsim, Laura E. Crotty Alexander, Kevin G. Blyth, Caroline Kelly, Jayne Holme, Alistair S. McLaren, Patricia Roxburgh and Ewen T. Ross. Their work appears in journals such as The Lancet, Annals of Oncology, Lung Cancer, Clinical Oncology and Current Issues in Criminal Justice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.